Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2005
12/27/2005US6979445 Method for treating von willebrand's disease
12/27/2005CA2428271C Cyanopyrrolidine derivatives as inhibitors of dpp-iv
12/27/2005CA2346961C Patient temperature regulation method and apparatus
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/27/2005CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
12/27/2005CA2188887C Nutritional coffee composition
12/27/2005CA2131911C Minimizing progestin associated breakthrough bleeding
12/22/2005WO2005121340A1 Novel galectin 8 modification protein and use thereof
12/22/2005WO2005121153A1 Condensed pyrimidine derivative and xanthine oxidase inhibitor
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121126A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005WO2005121112A1 Medicinal compositions containing 6-hydroxybenz- bromarone or salts thereof
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
12/22/2005US20050282999 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282905 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
12/22/2005US20050282899 Resorcinol derivatives
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282880 Novel 1H-indazole compounds
12/22/2005US20050282876 Inhibitors of IMPDH enzyme
12/22/2005US20050282869 Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess therewith
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282865 Neurotrophic factor production promoter
12/22/2005US20050282845 Substituted pyrimidines as selective cyclooxygenase-2 inhibitors
12/22/2005US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity
12/22/2005US20050282815 Substituted N-(heteroar-beta-yl)aminopyridinecarboxamides or benzamides, e.g., 2-amino-4-fluoro-5-(1-methyl-1H-imidazol-2-ylsulfanyl)-N-(4-methylthiazol-2-yl)benzamide; glucokinase activators used to treat diabetes mellitus or obesity
12/22/2005US20050282810 Oxindole derivatives
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282786 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
12/22/2005US20050282769 Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
12/22/2005US20050282766 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
12/22/2005US20050282746 DNA encoding the receptor, a transformed cell expressing the receptor, producing the receptor by culturing the transformed cells; receptor binding assays; drug screening for agonists, antagonists, or allosteric modulators
12/22/2005US20050282742 Such as bortezomib, by freeze drying
12/22/2005US20050282737 Procollagen (III) propeptides and related substances for treating fibrotic diseases
12/22/2005US20050282730 xanthocillin analogues such as 3,3'-Dimethoxyxanthocillin X dimethyl ether, used for increasing platelets in a human having a disease selected from thrombocytopenia caused by bone marrow grafting, surgery, infection, intestinal bleeding, anemia, myelodysplastic syndrome, and thrombopoietin deficiency
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050281910 Method for increasing pet activity
12/22/2005US20050281900 Plant extract of the species Vitis vinifera as no-synthase inhibitor and uses
12/22/2005US20050281864 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock
12/22/2005US20050281825 peptide transport proteins (PepTs); has antibody-dependent cell-mediated cytotoxic (ADCC) activity; cancer
12/22/2005US20050281804 Administering human recombinant alpha -L-iduronidase, carrier and polysorbate for therapy of mucopolysaccharidosis
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050281793 T cell activation
12/22/2005US20050281787 Tumor-specific vector for gene therapy
12/22/2005US20050281764 Use of EGF-R protein tyrosine kinase inhibitors for preventing photoaging in human skin
12/22/2005DE19814084B4 D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's disease and process for its preparation
12/22/2005CA2561831A1 Polycyclic pyrazines as potassium ion channel modulators
12/21/2005EP1607744A2 Treatment of diseases involving cyst formation with combinations comprising a PTBR agonist
12/21/2005EP1607401A1 Novel aryl fructose-1,6-Bisphosphatase inhibitors
12/21/2005EP1607399A2 BIS-(N,N'-BIS-(2-Haloethyl)Amino) Phosphoramidates as antitumor agents
12/21/2005EP1607384A1 Novel functional peptide nucleic acid and process for producing the same
12/21/2005EP1607102A1 Preventive for adhesion following abdominal surgery
12/21/2005EP1607100A1 Remedy for spinal injury containing interleukin-6 antagonist
12/21/2005EP1607099A1 Use of hyperforin derivatives as an antidepressant agent
12/21/2005EP1606307A1 ESTRIENO(3,2-b)/(3,4-c)PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS
12/21/2005EP1605954A1 A food-supplement composition suitable for promoting iron absorption
12/21/2005EP1605947A1 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
12/21/2005EP1605930A1 Use of arachidonic acid for normalization of infradian rhythm
12/21/2005EP1490391B1 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring substituted with a long chain at the 11beta position
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1429780B1 Method of treating middle ear infections
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1379547B1 Modified cyclosporin as a pro-drug and use thereof as a medicament
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1313738B1 Process for the preparation and purification of thiol-containing maytansinoids
12/21/2005EP1286674A4 Methods and compositions for potentiating cancer chemotherapeutic agents
12/21/2005EP1282402B1 Stabilized aqueous suspensions for parenteral use
12/21/2005EP1278759B1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1220934B1 Methods for making recombinant proteins using apoptosis inhibitors
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP1196442B1 Vgf polypeptides and methods of treating vgf-related disorders
12/21/2005EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation
12/21/2005EP1119581B1 USE OF A VECTOR EXPRESSING RB2/p130 FOR PREVENTION OR TREATMENT OF RESTENOSIS OR ATHEROSCLEROTIC PLAQUES
12/21/2005EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
12/21/2005EP1066038B1 Use of cabergoline in the treatment of restless legs syndrome
12/21/2005EP0713393B1 Estrogenic compounds as anti-angiogenesis agents
12/21/2005EP0579819B1 Novel pyridone derivative having an affinity for the angiotensine ii receptor
12/21/2005CN1711107A Remedy for glaucoma comprising Rho kinase inhibitor and beta-blocker
12/21/2005CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity
12/21/2005CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232252C Retard release preparation containing alpha-lipoic acid (derivatives)
12/21/2005CN1232189C Anti-fatigue oral liquor
12/20/2005US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/20/2005US6977296 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977259 Quinoline derivatives and their use as aurora 2 kinase inhibitors
12/20/2005US6977258 Antiinflammatory agents; cardiotonic agents; rheumatic diseases
1 ... 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 ... 1564